The levels of the storage form of cholesterol, CE, are increased in brain samples of late onset of AD (LOAD) [145], in brain from transgenic PS1-APP [148] and APP/tau [145] mice, and in AD patient-derived neurons [149]. Here, MAPT is linked to Alzheimer disease.